UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic

Nature communications, 2021-05, Vol.12 (1), p.2637-14, Article 2637

2021

Volltextzugriff (PDF)

Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)

Molecular cancer therapeutics, 2015-09, Vol.14 (9), p.2060-2071

2015

Volltextzugriff (PDF)

Ligand-directed targeting of genes to the site of disease

Nature medicine, 2003-01, Vol.9 (1), p.135-139

Wickham, Thomas J

2003

Volltextzugriff (PDF)

Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1517-1527

2016

Volltextzugriff (PDF)

Identification of a Conserved Receptor-Binding Site on the Fiber Proteins of CAR-Recognizing Adenoviridae

Science (American Association for the Advancement of Science), 1999-11, Vol.286 (5444), p.1568-1571

1999

Volltextzugriff (PDF)

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study

British journal of cancer, 2018-10, Vol.119 (9), p.1086-1093

2018

Volltextzugriff (PDF)

The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors

Human gene therapy, 2003-05, Vol.14 (7), p.627-643

2003

Volltextzugriff (PDF)

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer

BMC cancer, 2016-06, Vol.16 (1), p.352, Article 352

2016

Volltextzugriff (PDF)

Epitopes Expressed in Different Adenovirus Capsid Proteins Induce Different Levels of Epitope-Specific Immunity

Journal of Virology, 2006-06, Vol.80 (11), p.5523-5530

2006

Volltextzugriff (PDF)

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

Nature biotechnology, 1996-11, Vol.14 (11), p.1570-1573

1996

Volltextzugriff (PDF)

Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients

The American journal of pathology, 2013-11, Vol.183 (5), p.1446-1460

2013

Volltextzugriff (PDF)

Impact of tumor HER2/ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effect

Molecular cancer therapeutics, 2013-09, Vol.12 (9), p.1816-1828

2013

Volltextzugriff (PDF)

Modification to the Capsid of the Adenovirus Vector That Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses

Journal of Virology, 2004-03, Vol.78 (5), p.2572-2580

2004

Volltextzugriff (PDF)

Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment

Nanomedicine, 2019-04, Vol.17, p.71-81

2019

Volltextzugriff (PDF)

Activation of p38 and ERK Signaling during Adenovirus Vector Cell Entry Lead to Expression of the C-X-C Chemokine IP-10

Journal of Virology, 2002-02, Vol.76 (4), p.1559-1568

2002

Volltextzugriff (PDF)

Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15

Cancer Immunology, Immunotherapy, 2021-09, Vol.70 (9), p.2701-2719

2021

Volltextzugriff (PDF)

HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity

Toxicology and applied pharmacology, 2012-07, Vol.262 (1), p.1-10

2012

Volltextzugriff (PDF)

Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins Is Not Required To Elicit Brain Inflammation but Is Necessary To Transduce Specific Neural Cell Types

Journal of Virology, 2002-04, Vol.76 (7), p.3452-3460

2002

Volltextzugriff (PDF)

Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism Abolished

Journal of Virology, 2002-03, Vol.76 (6), p.2753-2762

2002

Volltextzugriff (PDF)

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

Cancer gene therapy, 2004-07, Vol.11 (7), p.477-486

2004

Volltextzugriff (PDF)

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (15), p.4190-4202

2017

Volltextzugriff (PDF)

The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F

Journal of Virology, 1998-10, Vol.72 (10), p.7909-7915

1998

Volltextzugriff (PDF)

Reducing the Native Tropism of Adenovirus Vectors Requires Removal of both CAR and Integrin Interactions

Journal of Virology, 2001-12, Vol.75 (23), p.11284-11291

2001

Volltextzugriff (PDF)

Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models

Cancer gene therapy, 2000-01, Vol.7 (1), p.13-19

2000

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(110)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(67)
Humans
(49)
Animals
(38)
Adenoviridae - Genetics
(25)
Biological And Medical Sciences
(22)
Gene Therapy
(22)
Adenovirus
(21)
Genetic Vectors
(19)
Mice
(19)
Virology
(18)
Biotechnology & Applied Microbiology
(17)
Medicine, Research & Experimental
(17)
Oncology
(17)
Research & Experimental Medicine
(17)
Female
(16)
Gene Transfer Techniques
(16)
Fundamental And Applied Biological Sciences. Psychology
(15)
Receptors, Virus - Metabolism
(15)
Genetics & Heredity
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic

Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)

Ligand-directed targeting of genes to the site of disease

Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer

Identification of a Conserved Receptor-Binding Site on the Fiber Proteins of CAR-Recognizing Adenoviridae

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study

The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer

Epitopes Expressed in Different Adenovirus Capsid Proteins Induce Different Levels of Epitope-Specific Immunity

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients

Impact of tumor HER2/ERBB2 expression level on HER2-targeted liposomal doxorubicin-mediated drug delivery: multiple low-affinity interactions lead to a threshold effect

Modification to the Capsid of the Adenovirus Vector That Enhances Dendritic Cell Infection and Transgene-Specific Cellular Immune Responses

Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment

Activation of p38 and ERK Signaling during Adenovirus Vector Cell Entry Lead to Expression of the C-X-C Chemokine IP-10

Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15

HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity

Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins Is Not Required To Elicit Brain Inflammation but Is Necessary To Transduce Specific Neural Cell Types

Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism Abolished

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer

GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes

The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F

Reducing the Native Tropism of Adenovirus Vectors Requires Removal of both CAR and Integrin Interactions

Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models

Suchergebnisse filtern